PEAK6 Investments’s GeneDx Holdings WGS Stock Holding History

PEAK6 Investments’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-455	Closed	-$114K	–	5877
2021 Q3	$114K	Buy	+455	New	+$156K	﹤0.01%	4289

Other funds holding WGS

Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return

PEAK6 Investments's WGS Position: Q4 2021 in Review

PEAK6 Investments sold out of GeneDx Holdings (WGS) in Q4 2021, closing a stake of 455 shares — an estimated $114K sold.

PEAK6 Investments first reported a position in WGS in Q3 2021 and held it in 1 quarter. The position peaked at $114K in Q3 2021. 112 funds tracked by Wall St. Rank hold WGS as of Q4 2021.

PEAK6 Investments reported no remaining GeneDx Holdings position as of Q4 2021 after selling out during the quarter.
PEAK6 Investments sold 455 GeneDx Holdings shares in Q4 2021, an estimated $114K.
PEAK6 Investments first reported a position in GeneDx Holdings in Q3 2021 and held it in 1 quarter.
PEAK6 Investments's GeneDx Holdings position peaked at $114K in Q3 2021.
112 funds tracked by Wall St. Rank held GeneDx Holdings as of Q4 2021.

Based on PEAK6 Investments's 13F filing for Q4 2021, filed 11 Feb 2022.